Background/Aims: The COVID-19 disease, which was declared epidemic by the WHO, is a global emergency public health problem. Patients with extrapulmonary symptoms are the group of patients who should be considered for person-to-person transmission in the community. In our study, it was aimed to investigate the characteristics of patients with COVID-19-related diarrhea symptoms. Materials and Methods: The study was conducted retrospectively in CO-VID-19 rtRT-PCR-positive patients in 5 medical centers. Three or more loose/liquid stools per day or increased number of defecations compared to normal defecation were defined as diarrhea. The patients were analyzed in 2 groups as those with and without diarrhea. Results: One thousand eighty-six patients were included in the study. Seventy-eight (7.2%) of the patients had diarrhea. Diarrhea was watery in 54 (69.2%) patients while with blood and mucus in 18 (23.1%) patients. Diarrhea continued for an average of 5.2 ± 1.6 (2–11) days. The clinical and laboratory findings of patients with diarrhea were more serious than those without diarrhea. Diarrhea is more common in the elderly and people with comorbid disease, and patients with diarrhea had higher CMI score and CRP and higher complaints of fever, cough, shortness of breath, myalgia, and fatigue. Conclusions: The presence of diarrhea should indicate a suspected COVID-19 infection and suggest testing for early diagnosis of the disease. It should be kept in mind that the course of the disease may be more severe in these patients, and precautions should also be taken in terms of fecal transmission during discharge.

1.
D'Amico
F
,
Baumgart
DC
,
Danese
S
,
Peyrin-Biroulet
L
.
Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management
.
Clin Gastroenterol Hepatol
.
2020
;
18
(
8
):
1663
72
. .
2.
Li
XY
,
Dai
WJ
,
Wu
SN
,
Yang
XZ
,
Wang
HG
.
The occurrence of diarrhea in COVID-19 patients
.
Clin Res Hepatol Gastroenterol
.
2020
;
44
(
3
):
284
5
. .
3.
Pan
L
,
Mu
M
,
Yang
P
,
Sun
Y
,
Wang
R
,
Yan
J
,
Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study
.
Am J Gastroenterol
.
2020
;
115
(
5
):
766
73
. .
4.
Luo
S
,
Zhang
X
,
Xu
H
.
Don’t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19)
.
Clin Gastroenterol Hepatol
.
2020
;
18
(
7
):
1636
7
. .
5.
Guan
WJ
,
Ni
ZY
,
Hu
Y
,
Liang
WH
,
Ou
CQ
,
He
JX
,
China medical treatment expert group for Covid-19: clinical characteristics of coronavirus disease 2019 in China
.
N Engl J Med
.
2020
;
382
(
18
):
1708
20
.
6.
Tian
Y
,
Rong
L
,
Nian
W
,
He
Y
.
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission
.
Aliment Pharmacol Ther
.
2020
;
51
(
9
):
843
51
. .
7.
Hoffmann
M
,
Kleine-Weber
H
,
Schroeder
S
,
Krüger
N
,
Herrler
T
,
Erichsen
S
,
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
.
Cell
.
2020
;
181
(
2
):
271
e8
. .
8.
Wang
HG
,
Xie
R
,
Ma
TH
,
Yang
XZ
.
Excessive anxiety in IBD patients is unnecessary for COVID-19
.
Clin Res Hepatol Gastroenterol
.
2020
;
S2210-7401
(
20
):
30072
3
.
9.
Patel
KP
,
Patel
PA
,
Vunnam
RR
,
Hewlett
AT
,
Jain
R
,
Jing
R
,
Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19
.
J Clin Virol
.
2020
;
128
:
104386
. .
10.
Tang
A
,
Tong
ZD
,
Wang
HL
,
Dai
YX
,
Li
KF
,
Liu
JN
,
Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China
.
Emerg Infect Dis
.
2020
;
26
(
6
):
1337
9
. .
11.
Xie
C
,
Jiang
L
,
Huang
G
,
Pu
H
,
Gong
B
,
Lin
H
,
Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests
.
Int J Infect Dis
.
2020
;
93
:
264
7
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.